Progenity Inc
Biotechnology
Healthcare
PROG
95.85M shares
NASDAQ US
traded
28 Mar 2022
listed
yes
open
1.75
52 week high
7.31
high
1.75
52 week low
1.33
low
1.53
growth
-58.4%
previous Close
1.69
P/E ratio
-4
market cap
324M
div yield
0
usd
Sep 2021
qoq
revenue
182K
-60.69 %
net incoming
-43.74M
44.30 %
eps
-0.46
62.60 %
eps surprise
2.13 %
net profit margin
-24035.16 %
-7073.00 %
operating incoming
-30.56M
14.28 %
net change in cash
-11.86M
-1,758.04 %
cash on hand
54.14M
-17.96 %
cost of revenue
top top